Associate Professor of Medicine, University Wash

Oncology

Dr. Renato G. Martins, MD

Doctor Renato G. Martins, MD practices Oncology. He received awards:"America's Top Doctors" and "America's Top Doctors for Cancer". Renato G. Martins has written publications. He has 32 publications published with PubMed. The lastest paper is: 'Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.' He accepts Medicare.

Publications

Salivary Gland Malignancies.
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Ca...
ERCC1 is a prognostic biomarker in locally advanced head and neck Cancer: results from a randomised, phase II trial.
Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial.
Squamous cell carcinoma of the oral tongue in a patient with Fanconi Anemia treated with radiotherapy and concurrent cetuximab: A case report and review of the literat...
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer.
Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung Cancer.
Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell Carcinoma of the head and neck.
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid Cancer and metastatic medullary carcinoma of the thyroid with functiona...
Maintenance chemotherapy in non-small cell lung Cancer.
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung Cancer.
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid Cancer.
Thymic Carcinoma associated with paraneoplastic polymyositis.
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung Cancer: surgical and oncologic outcomes.
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell Cancer.
Motesanib diphosphate in progressive differentiated thyroid Cancer.
Response to paclitaxel in adenoid cystic carcinoma of the salivary Glands.
18F FDG-PET/CT findings in recurrent respiratory papillomatosis.
First-line gefitinib in patients with advanced non-small-cell lung Cancer harboring somatic EGFR mutations.
Second-line and third-line chemotherapy for lung Cancer: use and cost.
Novel agents in the treatment of lung Cancer: Fourth Cambridge Conference.
Antagonism of platelet-derived growth factor receptor in non small cell lung Cancer: rationale and investigations.
Treatment of recurrent squamous cell Carcinoma of the skin with cetuximab.
Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung Cancer.
Medullary thyroid Cancer: options for systemic therapy of metastatic disease?
Treatment of locally advanced non-small cell lung Cancer with combination of chemotherapy and radiation.
Twenty-two years of phase III trials for patients with advanced non-small-cell lung Cancer: sobering results.
Management of thyroid Cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Autologous bone marrow transplantation versus MACOP-B in B-cell Lymphoma.
The Role of Chemotherapy in the Management of Stage IIIA Non-Small Cell Lung Cancer.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.

Procedures Preformed

HPC Transplantation (Stem Cell Transplant)
Plasmapheresis
Thoracentesis

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anemia
Bladder Cancer
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Choice Plus POS II
Blue Card PPO
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
Open Access Plus
Commercial Insurance Company
First Choice Health PPO
Coop Core
Medicare Advantage PFFS
HealthSmart
Humana
Kaiser Permanente
Connect
Medicaid
Medicare MCR
Molina
MultiPlan PPO
ODS Health Plan
PacificSource
Heritage Plus
Heritage Signature
Personal Option EPO
Preferred Provider Network PPN
Uniform Medical Plan Classic
Choice Plus POS
Navigate HMO
Navigate POS
Options PPO
United Healthcare
Wells Fargo Insurance
Worker's Compensation WC

Awards

America's Top Doctors
America's Top Doctors for Cancer

Education

Massachusetts General Hospital
Faculdade de Medicina da Universidade Federal do Rio de Janeiro

Hospital

UW Medicine/Harborview Medical Center
Seattle Children's Hospital
University of Washington Medical Center

Drug Facts

NPI NUMBER		1396821195
NPPES Provider LastName		MARTINS
NPPES Provider FirstName		RENATO
NPPES Provider ZIPCode		98109
NPPES Provider State		WA
Specialty Description		Medical Oncology
Total Claim Count		247.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1396821195
Last Name Of The Provider	MARTINS
First Name Of The Provider	RENATO
View All

Similar Doctors

	Dr. Damian J. Green, MD This Doctor is OpenDoctor Recommended.
	Dr. Sujata Rao, MD This Doctor is OpenDoctor Recommended.
	Dr. Bernardo H. Goulart, MD This Doctor is OpenDoctor Recommended.
	Dr. Julie R. Gralow, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. S K. Callahan, MD
	Dr. H J. Deeg, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Veena Shankaran, MD This Doctor is OpenDoctor Recommended.
	Dr. Hans-Peter Kiem, MD This Doctor is OpenDoctor Recommended.